platinum has been researched along with ursodeoxycholic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
el-Mir, MY; Herrera, MC; Marin, JJ; Mendoza, ME; Monte, MJ; Villanueva, GR | 1 |
Criado, JM; de La Fuente, A; Dominguez, MF; Izco-Basurko, I; Macias, RI; Marin, JJ; Monte, MJ; Pascual, MJ; Yajeya, J | 1 |
2 other study(ies) available for platinum and ursodeoxycholic acid
Article | Year |
---|---|
Effect of bile acids on hepatobiliary transport of cisplatin by perfused rat liver.
Topics: Animals; Antineoplastic Agents; Bile; Bile Acids and Salts; Bile Ducts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cisplatin; Glycocholic Acid; In Vitro Techniques; Liver; Male; Perfusion; Platinum; Rats; Rats, Wistar; Ursodeoxycholic Acid | 1997 |
Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Cisplatin; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Kidney; Kidney Function Tests; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Myocardium; Neoplasm Transplantation; Neural Conduction; Organoplatinum Compounds; Platinum; Rats; Rats, Wistar; Sciatic Nerve; Survival Rate; Tissue Distribution; Tumor Cells, Cultured; Ursodeoxycholic Acid | 2001 |